Alkermes ALKS
NASDAQ ALKS
$44.11 +1.14 (+2.65%)
At close: Oct 20, 2026 · 4:00 PM EDT

Alkermes (ALKS) Restructuring Costs (2014 - 2015)

Updated

Alkermes (ALKS) recorded Restructuring Costs of $13.4 million in FY2019.

Analysis

Alkermes (ALKS) Restructuring Costs (2014 - 2015) Analysis & Trends

  • Annual Restructuring Costs has a five-year compound annual growth rate of 8.8% (FY2014 to FY2019).
  • The FY2019 figure is the lowest annual Restructuring Costs since FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Alkermes 7.37 Bn 4.50 Bn 397.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 255,000.00
Dec 31, 2014 2.45 Mn
Sep 30, 2014 3.52 Mn
Jun 30, 2014 1.86 Mn
Mar 31, 2014 946,000.00
API Access

Alkermes Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=ALKS&period=max&api_key=YOUR_API_KEY